A new publication involving bivalirudin was listed on October 5, 2026. The paper, titled "Engineering Immunomodulatory Stents Using a Biomimetic Nanozyme System for Vascular Healing," appeared in the journal Advanced Materials (Deerfield Beach, Fla.).
The publication is indexed under PubMed ID 42830705. No findings, outcomes, or efficacy data from the study are included in this brief, as only the publication record itself has been reported.
Bivalirudin remains an approved compound. This listing reflects a new entry in the scientific literature rather than a change in its regulatory status or approved use.
Readers interested in the broader context of bivalirudin, including its approved status and general background, can consult the compound overview for further information.